Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
Residential and Outpatient Schizophrenia Patients' Sleep Health Varies.
Read Full NewsEurope will need to rethink how it values and pays for innovative medicines or risk losing manufacturing investments and clinical trials, the head of Europe's pharmaceutical industry lobby said.
Patients, doctors, and other healthcare professionals who spoke with KFF Health News say the effort has created confusion, errors, long wait times, and stress.
Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.
Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.
MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4, and when primary care can manage MASLD without a specialist.
Palbociclib is now the first CDK4/6 inhibitor approved for metastatic disease regardless of HER2 status.
Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for patients with platinum-sensitive ovarian cancer.
1.
According to research, hospitals can save money and help cancer patients by implementing a basic intervention.
2.
Radiation therapy for patients with breast cancer
3.
Relationship-building key to addressing oncologist shortages in rural care
4.
What Patients Hear From Us: 'Blah, Blah, Tumor, Blah, Blah, Cancer'
5.
Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy
1.
Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options
2.
Clinical Insights in Hematology in Daily Practice
3.
Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights
4.
Introduction to Immune Thrombocytopenic Purpura
5.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge